Click here to register for May 14 investor webcastCompany plans to file its Earnings Report on May 14, 2024 on…
Click here to register for May 14 investor webcastCompany plans to file its Earnings Report on May 14, 2024 on…
NV-387 Possesses Strong Orthopoxvirus Activity Relevant to Both Sexual and Inhalation Modes of Transmission, Says NanoViricides SHELTON, CT / ACCESSWIRE…
Alistair Macdonald brings over 30 years of biopharmaceutical and life sciences leadership experience to Envision Pharma Group's Board of DirectorsFAIRFIELD,…
STOCKHOLM, Sweden / ACCESSWIRE / May 8, 2024 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB ("iZafe Group"), in collaboration with…
GOTHENBURG, SWEDEN / ACCESSWIRE / May 8, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 8, 2024 - IRLAB Therapeutics…
GENEVA, SWITZERLAND / ACCESSWIRE / May 8, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical…
NEWARK, CA / ACCESSWIRE / May 7, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") (NASDAQ:PTGX) today announced that…
Entered into a worldwide license and collaboration agreement for rusfertide with Takeda; Cash runway extended through Q4 2027 [1] Enrollment…
Curia & Carterra Biologics Symposium Biologics symposium slated for May 31 in Seattle, WA ALBANY, N.Y. and SALT LAKE CITY,…